BBK Worldwide Appoints New President
Longtime Head of Innovation Matthew Kibby Accelerates Company’s Strategy to Equip Industry with Patient-Centric Technologies and Programs
Boston, Mass., June 14, 2016 – BBK Worldwide, an industry leader in patient recruitment and engagement technologies and services, has appointed Matthew Kibby as President and Chief Innovation Officer. Kibby has held a variety of senior positions in his 19-year tenure with the company and most recently led the company’s tech innovation and product development groups.
As President, Kibby will steer the patient recruitment leader to achieve its vision of clinical research best practices that address patient needs and improve patient engagement. Kibby will continue to report to BBK CEO and Founding Principal Joan F. Bachenheimer. “Matt’s deep technology expertise and leadership, combined with his passion for BBK’s vision will ensure that we continue to lead the industry during this next stage of growth,” said Bachenheimer.
Under Kibby’s strategic guidance and leadership, BBK’s flagship product, TrialCentralNet®, evolved to become an enterprise-grade, fully customizable patient recruitment and campaign management platform, utilized by the world’s top pharmaceutical, biopharmaceutical and CRO companies. Kibby will lead the company through its next phase of growth fueled in large part by increased demand for patient- and site-facing mobile solutions, card-based study reimbursements and full-service travel concierge, all especially critical for rare disease studies where global travel is often a requirement.
“Thanks to a greater awareness of the power of patient centricity, we remain increasingly optimistic about our industry’s efforts to align on what was not long ago just a set of ideals,” said Kibby. “The rapid rise in demand for mHealth solutions in particular underscores that study teams are eager to implement best-in-class technologies for the benefit of the patient and the research.
For more than three decades, BBK has been pushing the boundaries of what’s possible in patient recruitment and retention, all while ensuring that the patient remains at the center of it all – and I am honored to play a greater role in contributing to BBK’s future influence in this arena,” continued Kibby.